Manchester Metropolitan University and Cambridge Medical Technologies Limited
Lead Participant:
MANCHESTER METROPOLITAN UNIVERSITY
Abstract
To develop a new to market, self-test, ‘home usable’ biomarker panel test for common cancers based on a totally new technology, detecting a broader range of cancers and having a level of accuracy beyond any currently available alternatives.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| MANCHESTER METROPOLITAN UNIVERSITY | £222,424 | £ 149,024 |
Participant |
||
| KTN LTD | ||
| CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED | ||
| MANCHESTER METROPOLITAN UNIVERSITY |
People |
ORCID iD |